Skip to main content

Interview with Current President David Traver about the Upcoming 45th Annual Scientific Meeting of the International Society for Experimental Hematology (ISEH)

In advance of the upcoming 45th Annual ISEH Scientific Meeting, we spoke with current ISEH president David Traver, Professor of Cellular and Molecular Medicine at the University of California San Diego, about the highlights of the upcoming meeting in his current hometown and his thoughts on the society.

What is the focus of this year’s ISEH meeting?
We have tried to maintain the excellent breadth in all major areas of hematopoiesis research, with cutting edge talks across each discipline.  For example, we have a superb lineup of speakers in our Gene and Cell Therapy session, as well as a variety of thought leaders in our Leukemia and Developmental Hematopoiesis sessions.  As always, we have also worked to highlight our best young scientists at the meeting.
Are there any new formats/features that are not to be missed?
Yes, speaking of our trainees, we have started a new Pre-meeting Workshop this year for 50 of our young scientists.  It will feature posters and several short talks by students and fellows.  This format will encourage informal interactions among our trainees and mentoring by several noted scientists in the field, including Jim Palis, Nancy Speck, Anna Bigas, Dan Kaufman, Marella de Bruijn, Mick Milsom, Sofie Singbrant, and Merv Yoder. 
Are there any particular speakers that you are excited are participating this year?
Well, as president it has been particularly fun to invite three of my favorite scientists to speak in the Presidential Symposium – Nancy Speck, Leonard Zon, and Gordon Keller.  This will really be a special treat to feature them together at our meeting in August.
What makes ISEH special?
ISEH has always been my favorite meeting as it is large enough to attract the top speakers in the field but small enough to feel like family.  There remains a core group that nearly always attends, making sustained interactions possible over the years.  In addition, it is the best meeting that I attend in regard to fostering meaningful interactions between our young scientists and the leaders in the field.  I think this is due to both informal scientific discussions over posters / trainee sessions and “Meet the Expert” style social sessions over drinks. 
How long have you been involved with the society?
My first real talk came at an ISEH meeting when I was a graduate student in Irv Weisman’s lab.  I remember being terrified to present in front of what seemed a huge and intimidating audience.  But the talk went well and served to introduce me to many of the fantastic scientists in our field that I continue to interact with today.
Is there an advantage to joining a society as a student or postdoc, rather than wait until it’s clear you will remain in the field?
I think so.  Aside from the obvious financial incentives, being part of the ISEH provides a real sense of community.  I recall being impressed at how easy it was to approach many of the brand-name scientists in the field when attending my first few ISEH meetings.  Their encouragement helped me want to stay and succeed in science, and within the hematopoiesis field in particular. 
Do you have any dream goals for the meeting or the society in years to come?
I hope that we can continue to improve the impact of our journal, Experimental Hematology.  It is the key to keeping our society and meeting going strong.  Most of our funding comes from the journal, so improving the quality of manuscripts submitted is more important than most realize.  We have seen a large increase in submissions over the past year, with similarly large increases in downloads from the website.  If we can keep this up, the impact factor (IF) should improve over the next few years.  With the journal publishing only a moderate number of papers per month, it actually doesn’t take a huge increase in citations to move the IF up in a significant manner.  If we can accomplish this, more will submit their work, with further increases in the IF to create a positive feedback loop.  This is key to maintaining a strong society and to continue our great meetings for years to come. 

We hope to see you at the upcoming ISEH meeting! To learn more about the meeting in San Diego this August 25-28, visit the ISEH website.

David Traver, PhD
Current ISEH President
Professor of Cellular and Molecular Medicine
Professor of Biology, Section of Cell and Developmental Biology
UC San Diego School of Medicine
La Jolla, CA USA
Trista E. North, PhD
Chair, ISEH Publications Committee
ISEH Board of Directors
Associate Professor of Pathology
Harvard Medical School
Beth Israel Deaconess Medical Center
Boston, MA USA






Popular posts from this blog

How to Make the Most Out of Your Lab’s Move

“The lab is moving!” I must confess, when I heard these words from my mentor about a year and a half ago, my heart dropped. Lab relocation experiences are some of the worst horror stories that you hear from fellow researchers: precious samples lost, mouse colonies never recovered, months spent re-establishing protocols. Moreover, it also meant I would have to leave San Francisco, a beautiful city that I loved to live in, and where I found many friends. Being a scientist often means not having much choice of geographic location of your work. The choice of a particular subject or even broad field usually requires a move to a new city, or even a new country. Moving with the lab means making this choice again – do I leave my project and all the progress behind, or do I accept the delay in my research and go ahead. Now, two months after our move to New York, I would like to reflect on my experiences and that of my fellow lab members on our cross-country relocation from the trainee perspect…

The cost of a postdoctoral experience and its impact on STEM diversity

Academic diversity in the biological sciences isn't what it should be.  At the most basic level, representation by underrepresented groups in the top research universities in the United States is less than 5%1.  Despite gains in enrollment of underrepresented students in the biological sciences at the undergraduate and doctoral levels, these gains do not extend to the tenure-track realm, where representation has changed very little over the past three decades. 

At another level, because of the ferocious degree of competition in science today - for publication in high impact journals, for limited grant funds, for fewer tenure-track positions -- one might argue that academic diversity is slowly been shaped by a "1%" mindset.  Perhaps more than ever before, the institution you come from-- even the lab you come from-- influences where you will publish, whether you will attain funding, and ultimately whether you will succeed. My purpose here is not to grumble; I'm sure th…

When people can…

As long as I can remember, there were people marching on the streets, either protesting or celebrating or even supporting the topic of the manifestation. It always fascinated me how powerful people can be, when they come together. In cases of manipulation of the public opinion this is of course not good. However, many times this can influence things in a positive way. Coming from a country like Greece, I have to admit that it was fairly frequent for me to see people getting together on the streets for a variety of reasons. Then, when I moved myself and my life to Boston, these events happened less frequently. I remember that I joined a protest in Boston once (although maybe this is not the right time to admit such a thing). It was about the Gulf war and people wanting their children to come back home. The subject of the protest was noble, however only a few people participated. Thus, it was to my great surprise and satisfaction when on April 22nd, 2017 the March for Science was organi…